- Home
- ULH vs CBLL Comparison
ULH vs CBLL Comparison
Compare ULH & CBLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ULH | CBLL |
|---|---|---|
| Founded | 1932 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trucking Freight/Courier Services | |
| Sector | Industrials | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 395.5M | 428.8M |
| IPO Year | 2005 | 2024 |
Fundamental Metrics
Financial Performance| Metric | ULH | CBLL |
|---|---|---|
| Price | $16.74 | $21.41 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 6 |
| Target Price | $17.00 | ★ $24.67 |
| AVG Volume (30 Days) | 72.5K | ★ 631.6K |
| Earning Date | 02-05-2026 | 11-04-2025 |
| Dividend Yield | ★ 2.58% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,638,101,000.00 | $82,813,000.00 |
| Revenue This Year | N/A | $37.43 |
| Revenue Next Year | $3.13 | $27.87 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 37.93 |
| 52 Week Low | $12.78 | $10.01 |
| 52 Week High | $48.99 | $29.70 |
Technical Indicators
Market Signals| Indicator | ULH | CBLL |
|---|---|---|
| Relative Strength Index (RSI) | 57.00 | 74.50 |
| Support Level | $15.96 | $19.87 |
| Resistance Level | $17.80 | $22.65 |
| Average True Range (ATR) | 1.08 | 1.13 |
| MACD | 0.26 | 0.13 |
| Stochastic Oscillator | 83.52 | 64.54 |
Price Performance
Historical ComparisonAbout ULH Universal Logistics Holdings Inc.
Universal Logistics Holdings Inc is an asset-light provider of customized transportation and logistics solutions throughout the United States, and in Mexico, Canada and Colombia. It offers services such as truckload, brokerage, intermodal, dedicated, and value-added services. The company reports into four segments namely trucking, intermodal, company-managed brokerage, and contract logistics. The majority of the revenue is earned from the contract logistics segment.
About CBLL CeriBell Inc.
CeriBell Inc is a commercial-stage medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The Company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining proprietary, portable and rapidly deployable hardware with sophisticated artificial intelligence (AI) powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions.